NasdaqCM - Delayed Quote • USD
Pulse Biosciences, Inc. (PLSE)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 5:01 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.49 | -0.25 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 200k | 9k | 700k | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 3/31/2023 | 6/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.45 | -0.24 | -0.22 | -0.22 |
| EPS Actual | -0.49 | -0.25 | -0.26 | -0.22 |
| Difference | -0.04 | -0.01 | -0.04 | 0 |
| Surprise % | -8.90% | -4.20% | -18.20% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
| 30 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
| 60 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
| 90 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PLSE | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 0.40% |
| Next Qtr. | -- | -- | -- | 9.90% |
| Current Year | -- | -- | -- | 4.30% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Downgrade | Maxim Group: Buy to Hold | 9/21/2022 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/13/2022 |
| Maintains | Stephens & Co.: Overweight | 4/1/2022 |
| Maintains | HC Wainwright & Co.: Buy | 4/1/2022 |
| Maintains | HC Wainwright & Co.: Buy | 2/10/2022 |
| Maintains | HC Wainwright & Co.: Buy | 11/16/2021 |
Related Tickers
KRMD KORU Medical Systems, Inc.
2.1400
+0.47%
NEPH Nephros, Inc.
2.1400
+3.88%
MLSS Milestone Scientific Inc.
0.5571
+3.17%
LMAT LeMaitre Vascular, Inc.
64.23
+2.33%
MMSI Merit Medical Systems, Inc.
74.18
+1.27%
NYXH Nyxoah S.A.
10.48
-4.03%
ICUI ICU Medical, Inc.
97.76
+1.43%
AKYA Akoya Biosciences, Inc.
3.8100
-2.31%
ATRC AtriCure, Inc.
23.17
+2.03%
OSUR OraSure Technologies, Inc.
5.53
+3.36%